Skip to main navigation Skip to search Skip to main content

2218P - REACtiVe-2: Phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer

Activity: OtherAcademic

Description

Poster presentation (2218P)
Period17 Oct 202521 Oct 2025
Event titleEuropean Society for Medical Oncology
Event typeConference
LocationBerlin, GermanyShow on map